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POU transcription factor Pou5f1 (Oct3/4) is required to maintain ES cells in an undifferentiated state. Here we show that global
expression profiling of Oct3/4-manipulated ES cells delineates the downstream target genes of Oct3/4. Combined with data
from genome-wide chromatin-immunoprecipitation (ChIP) assays, this analysis identifies not only primary downstream targets
of Oct3/4, but also secondary or tertiary targets. Furthermore, the analysis also reveals that downstream target genes are
regulated either positively or negatively by Oct3/4. Identification of a group of genes that show both activation and repression
depending on Oct3/4 expression levels provides a possible mechanism for the requirement of appropriate Oct3/4 expression
to maintain undifferentiated ES cells. As a proof-of-principle study, one of the downstream genes, Tcl1, has been analyzed in
detail. We show that Oct3/4 binds to the promoter region of Tcl1 and activates its transcription. We also show that Tcl1 is
involved in the regulation of proliferation, but not differentiation, in ES cells. These findings suggest that the global expression
profiling of gene-manipulated ES cells can help to delineate the structure and dynamics of gene regulatory networks.
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INTRODUCTION
Mouse embryonic stem (ES) cells, derived from the inner cell mass
(ICM) of blastocysts [1,2], can be maintained indefinitely in vitro
[3] in an undifferentiated self-renewing state in the presence of
Leukemia Inhibitory Factor (LIF) [4,5] and Bone Morphogenetic
Proteins (BMPs) [6]. The cells in culture can also retain their
ability to differentiate into all three germ layers both in vitro and in
vivo, and are thus as highly pluripotent as their in vivo counterparts,
ICM cells. The mechanisms underlying these phenomena have
been extensively studied [7–11], but it is likely that many of the
genes and regulatory mechanisms involved have yet to be
identified.
Two transcription factors, Oct3/4 (Pou5f1: POU domain class 5
transcription factor 1, also known as Oct3 and Oct4) [12–14], and
Nanog (variant homeobox protein) [15,16] are known to play
important roles in mouse ES cells. The expression of Oct3/4 is
restricted to pluripotent embryonic and germline cells [17]. In
blastocysts, Oct3/4 protein is more abundant in the ICM than in
trophectoderm cells, but in late blastocysts Oct3/4 protein is even
more abundant in primitive endoderm than in the ICM [18]. In
vitro, the reduction of Oct3/4 expression fosters differentiation of
ES cells into trophectoderm, i.e., placental lineage, whereas the
overexpression of Oct3/4 promotes differentiation into primitive
endoderm and mesoderm [19]. However, Oct3/4 cannot
maintain the undifferentiated state of ES cells without LIF.
Therefore, Oct3/4 is required but not sufficient for the
maintenance of undifferentiated ES cells [19,20]. In contrast, the
recently identified Nanog gene can bypass LIF-pathways and
maintain ES cells undifferentiated in the culture media without
LIF. However, Oct3/4 is demonstrably required for Nanog
function, because forced repression of Oct3/4 will allow ES cells to
differentiate independent of Nanog levels [8].
A first step to understand the function of Oct3/4 is to identify
downstream target genes. Fgf4, Utf1, Spp1/Opn, Fbxo15/Fbx15,
Sox2, Pdgfa/PDGFa, Cga/a,bhCG, Ifngr1/tINF, and Zfp42/Rex1
have been identified [9,21–27]; and screening by cDNA sub-
traction methods have also identified Otx2, Lefty1, and Upp1/Upp
as potential downstream target genes [28]. Recently Dppa5/Esg1
[29,30] and Nanog [31,32] have been added to the candidate gene
list. Some of these target genes are expressed specifically in ES cells
as well as in the ICM of blastocysts. However, their functions are
largely unknown, and Oct3/4 has not yet been linked to or
associated with critical physiological pathways.
Recently, genome-wide surveys of Oct3/4-binding sites have
been performed on human ES cells by chromatin-immunoprecip-
itation (ChIP)-on-chip assays [33] and on mouse ES cells by ChIP-
PET assays [34]. In human ES cells 581 genes have been identified
as Oct3/4-target genes, whereas 963 genes have been identified in
mouse ES cells. These studies have provided a list of genes that are
primary downstream targets of Oct3/4, and demonstrated
physical associations between transcription factor proteins and
promoter sequences in vitro. On the other hand, ChIP-on-chip or
ChIP-PET assays do not provide information about whether these
primary target genes are activated or repressed by Oct3/4
binding. In addition, secondary downstream target genes, which
are regulated by the primary target genes, cannot be identified by
such studies.
We have manipulated Oct3/4 levels in ES cells and carried out
expression profiling by microarray analysis to identify new
candidate genes as downstream targets of Oct3/4. We then
followed up one of them, Tcl1, as a pilot for systematic analyses,
and confirmed that it is indeed transcriptionally regulated by
Oct3/4 and involved in the control of ES cell proliferation.
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Global gene expression changes in Oct3/4-
manipulated ES cells
To study overexpression of Oct3/4, we used ZHTc6 ES cells, i.e.,
Pou5f1
+/2 ES cells transfected with a Tetracycline (Tet)-regulated
Pou5f1 transgene [19]. In this in vitro system, withdrawal of Tet
overexpresses Oct3/4 and differentiates ES cells into cells similar
to primitive endoderm and mesoderm. For Oct3/4 repression
studies, we used ZHBTc4 ES cells, which were made by disrupting
the remaining Pou5f1 allele of ZHTc6 ES cells [19]. Although both
Pou5f1 alleles were disrupted, the ZHBTc4 cells can be maintained
as undifferentiated by the continuous induction of an Oct3/4
transgene in the absence of Tet. Addition of Tet to the culture
media represses Oct3/4 and provokes differentiation of the ES
cells into cells similar to trophectoderm [19].
We carried out expression profiling of the ES cells in triplicate at
five time points (every 24 hrs: day 1, 2, 3, 4, and 5) after withdrawal
of Tet in ZHTc6 ES cells (for overexpression of Oct3/4) or after
addition of Tet in ZHBTc4 EScells (for repression of Oct3/4) using
a 22K 60-mer oligonucleotide microarray [35] (Figure 1A). As
expected, in ZHTc6 cells the Oct3/4 expression level was induced
by 1.2-fold at day 2 and 2-fold at day 3 after withdrawal of Tet.
In ZHBTc4 cells, the Oct3/4 expression level immediately fell
5-fold and was maintained from day 1 after adding Tet. These
results were consistent with a previous report [19] and were further
confirmed by real time Q-PCR (data not shown).
As a first step toward assessing global trends, we identified
changes in expression levels of individual genes by examining
20,251 genes that showed consistently-replicated expression levels
(Supplemental Table S1). The expression patterns of these genes
in ZHTc6 cells and ZHBTc4 cells were analyzed separately using
a k-means clustering algorithm and grouped into ten clusters
(Figure 1B, C). Upper panels show the expression changes of
individual genes in a 3D landscape map, whereas lower panels
show the pattern of averaged gene expression changes and the
number of genes grouped into each cluster. There were marked
differences in the expressions of many genes between ZHTc6 cells
and ZHBTc4 cells. In ZHBTc4 cells, genes showed relatively
consistent trends over 5 days, whereas in ZHTc6 cells, larger
numbers of genes responded rapidly, but were restored to original
levels by day 3 (Figure 1B, C). The transient alteration of large
numbers of genes in ZHTc6 cells could reflect the complexity of
gene expression regulation by Oct3/4, or may instead reflect the
presence of heterogeneous cell populations in ZHTc6 cultures, as
evidenced by the upregulation of markers for broader cell types,
including primitive/definitive endoderm (Gata6, Gata4 and Afp),
mesoderm (T, Gsc), and ectoderm (Cdh2, Mbp, Nefl) (Supplemental
Figure S1, Supplemental Table S4).
To further compare the gene expression changes between the
Oct3/4-repression condition (ZHBTc4) and Oct3/4-overexpres-
sion condition (ZHTc6), we plotted the fraction of genes in each
cluster of ZHTc6 cells present in each cluster of ZHBTc4 cells
(Figure 1D). Four major peaks were observed. In ZHBTc4 cells
nearly half the genes (69 genes out of 144 genes) in cluster 1 and
20% of the genes (143 out of 667 genes) in cluster 4 were grouped
in cluster 10 in ZHTc6 cells (Figure 1D, green arrow). This
indicates that genes downregulated under Oct3/4-repression
conditions tend to be also downregulated under Oct3/4-over-
expression conditions. This group of 212 genes (129 unique gene
symbols) included known direct targets of Oct3/4 such as Spp1/
Opn, Sox2, Fbxo15, Otx2, and Zfp42/Rex1, as well as newly
identified direct targets of Oct3/4 by genome-wide chromatin
immunoprecipitation (ChIP) assays [33,34] (Figure 1E; Supple-
mental Table S2). In ZHBTc4 cells, nearly half the genes (84 genes
out of 223 genes) in cluster 5 and 13% of the genes (122 out of 906
genes) in cluster 2 were grouped in cluster 1 in ZHTc6 cells
(Figure 1D, red arrow). Thus, genes upregulated under the Oct3/
4-repression conditions tend to be also upregulated under the
Oct3/4-overexpression conditions. This group of 206 genes (180
unique gene symbols) included Igf2, Krt1-18, and Krt2-8, which are
known for their high expression in differentiated cells (Figure 1E;
Supplemental Table S3).
The diagram in Figure 1E summarizes this unique mode of
gene expression regulation by Oct3/4. Some of the direct Oct3/4
target genes seem to be regulated by Oct3/4 in a bell-shaped dose-
response manner or in an inverse bell-shaped dose-response
manner. It is thus inappropriate to simply classify all Oct3/4-
downstream genes as positively or negatively regulated by Oct3/4.
Bell-shaped expression regulation by Oct3/4 has been first
demonstrated using tandem Octamer motif promoter constructs
[36]. It has also been demonstrated that both low and high levels
of Oct3/4 repress the Zfp42/Rex1 promoter, whereas interme-
diate levels of Oct3/4 expression activate the Zfp42 promoter
[24]; Lower panel in Figure 1E). The current results have not only
confirmed these earlier works, but established that this is rather
common mode of expression regulation by Oct3/4, because many
other genes show similar expression patterns. Furthermore, the
current analysis has revealed that genes that show the inverse bell-
shaped expression pattern exist. That is, low and high levels of
Oct3/4 activate the promoter, but intermediate levels of Oct3/4
repress the gene promoter (upper panel in Figure 1E). These gene
regulation relationships perhaps underlie a unique mechanism of
Oct3/4 regulation, which is required to be maintained in a narrow
range of appropriate expression for maintenance of pluripotency:
either the increase or decrease of Oct3/4 levels from the
intermediate range leads to the differentiation of ES cells [19].
Identifying Oct3/4 downstream genes
To obtain a list of Oct3/4-downstream candidate genes, we first
used Principal Component Analysis (PCA). PCA can dissect multi-
dimensional data into a small number of major trends [37]. We
have focused here on the more tractable and uniformly-trending
microarray results for ZHBTc4 cells, although we have continued
the analyses of gene expression in both ZHBTc4 and ZHTc6 and
the results of parallel analysis of ZHTc6 cells are presented in
Supplementary materials (Supplemental Figure S1, Supplemental
Table S1). We concentrated on 3,079 genes that showed
statistically significant changes with time by ANOVA statistics
(FDR,0.05). Of these, 2,757 non-redundant genes were used for
PCA (Supplemental Table S4).
Figure 2A shows a 2D-plot of results for ZHBTc4 cells over
5 days in PC2(2) and PC3(2) coordinates. The expression
patterns of individual genes contributing to each PC are shown
in Figure 2B. PC2(2), a major component with Oct3/4 (an
exogenous copy), Nanog, and Krt2-8 genes, represented unidirec-
tional changes (653 genes showing a gradual increase and 390 with
a gradual decrease). In contrast, PC3(2), a minor component with
Dnmt3b and Gata6 genes, represented transient changes followed
by recovery of gene expression (Figure 2B). Genes contributing to
PC2(2) seemed to be strongly correlated with the differentiation of
ES cells into the trophoblast cell lineage. Our previous microarray
analysis comparing the expression patterns of ES cells and
Trophoblast Stem (TS) cells [38] identified 1,411 genes as
expressed predominantly in ES cells and 1,882 genes as expressed
predominantly in TS cells (FDR,0.01) [29,39]. As expected,
a large fraction of genes (373 out of 653) in ZHBTc4-Group I were
more highly expressed in TS cells than in ES cells (Figure 2B),
Pou5f1-Regulated Genes
PLoS ONE | www.plosone.org 2 December 2006 | Issue 1 | e26Figure 1. Global gene expression analysis of Oct3/4 manipulated ES cells.(A) Experimental design of microarray analysis. Oct3/4-overexpressing ES
cells differentiate to primitive endoderm and mesoderm, whereas Oct3/4-repressed ES cells differentiate towards Trophectoderm. (B)(C) K-means
clusters of gene expression levels analyzed by TIGR MEV tool (http://www.tigr.org) and their landscape representations by MATLAB. (D) Comparison
of genes grouped in each cluster of ZHTc6 cells and ZHBTc4 cells. The arrows (red and green) show highly correlated clusters between two cell lines
(see Materials and Methods). (E) Diagram summarizing the unique mode of gene expression regulation by Oct3/4. Representative Genes identified as
the direct downstream targets of Oct3/4 by the ChIP-on-chip assay [33] or ChIP-PET assay [34] are shown. Spp1 and Zfp42 (marked with asterisk) were
not detected as a direct downstream target by either ChIP-on-chip or ChIP-PET assays, but have already been shown as such by more direct
experimental methods (see the text).
doi:10.1371/journal.pone.0000026.g001
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were more highly expressed in ES cells than in TS cells (Figure 2B,
Supplemental Table S4).
Interestingly, most of the genes known to be downstream of
Oct3/4, such as Lefty1, Otx2, Spp1/Opn, Zfp42, Upp1/Upp, and
Fbxo15, as well as genes important for pluripotency, such as Nanog
and Sox2 (Figure 2C), were included in ZHBTc4-Group II
(Figure 2B). These genes were expressed in undifferentiated ES
cells and were progressively downregulated as the level of Oct3/4
was repressed (Figure 2B). These results suggests that genes in
ZHBTc4-Group II (390 genes) are reasonable candidates for genes
downstream of Oct3/4 (Figure 2C). On the other hand, con-
sidering the ability to Oct3/4 to activate or repress downstream
genes, genes in ZHBTc4-Group I (653 genes) should also be
considered to be candidates for genes downstream of Oct3/4
(Figure 2B). These 1043 formed our ‘‘list 1’’ of Oct3/4-
downstream candidate genes (Supplemental Table S4).
As an alternative way to identify a list of Oct3/4-downstream
candidate genes, we looked for genes with an early response to the
repression of Oct3/4 by comparing the gene expression patterns
between ZHBTc4 ES cells at 0 hr and 24 hrs of Tet-induction. A
stringent statistical criterion (FDR,0.1) identified 2164 down-
regulated genes and 2464 up-regulated genes (Supplemental Table
S5). These 4628 genes formed our ‘‘list 2’’ of Oct3/4-downstream
candidate genes. Thirty genes that showed the highest-fold
expression changes are shown in Figure 2D.
Figure 2. Principal component analysis (PCA) and the expression pattern heatmap of known target genes for Oct3/4 and related genes. (A) 2D-views
of PCA for 2,757 genes that were identified as significantly differentially expressed during this time course. (B) The expression pattern and ES/TS
specificity of each component of PCA was classified into 4 groups (Group I , Group IV). (C) Known target genes for Oct3/4 and related genes. (D) Top
30 up- and down-regulated genes from 0 h v 24 h.
doi:10.1371/journal.pone.0000026.g002
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target genes
It is reasonable to assume that the Oct3/4-downstream candidate
genes identified here include both primary target genes and the
secondary/tertiary target genes, which are regulated by the
primary target genes. To delineate Oct3/4-regulated gene
cascades or networks, it is important to distinguish primary target
genes from those which are indirectly regulated.
One approach is to analyze genomic sequence to search for
Oct3/4-binding motifs. However, it is generally difficult to identify
primary targets of Oct3/4 by searching for canonical octamer
motifs, 59-ATTA/TGCAT-39, because it has been shown that
Oct3/4 can bind to other similar sequence motifs such as 59-
ACTAGCAT-39 and 59-ATCAGCAT-39 [34,40]. Furthermore,
binding at the octamer motif is not unique to Oct3/4, but
common to all Oct gene family members, e.g., Oct1. To reduce
the large number of targets identified by the use of degenerate
consensus sequence motifs, we searched for clusters of multiple
OCT binding sites within 28k bt o+2 kb from transcription start
sites of all possible genes in the mouse genome. However, even the
search for genes carrying clusters of at least three sites with
sequence conservation (.50% compared to the human genome
sequence) identified 9326 target genes (Supplemental Table S6),
and the search for genes carrying the clusters of at least five sites
with the sequence conservation (.50%) and mismatch score
(,0.05) identified 4396 target genes (Supplemental Table S7).
Without experimental validations of individual Oct3/4-target
genes, the utility of genes identified by searching octamer-binding
motifs are limited at this point.
Another approach is to use a genome-wide chromatin
immunoprecipitation (ChIP) assay and to identify all promoter
sequences that are bound by Oct3/4. Recently, Boyer et al. have
conducted a large scale analysis of promoter binding for OCT4
in human ES cells using ChIP-Chip technologies [33]. They
demonstrated that OCT4 was associated with 581 of the promoter
regions for known protein-coding genes in the 28k bt o+2k b
region, relative to the transcription start site. Similarly, Loh et al.
have identified 963 genes as a direct downstream target of Oct3/4
in mouse ES cells using a ChIP-PET (paired-end ditag) assay [34].
We compared our Oct3/4 downstream gene lists with the data by
Loh et al and Boyer et al (Figure 3A). Only a small fraction of genes
(61 genes) overlap between human ES [33] and mouse ES cell data
[34] (Figure 3A). This is partially due to the biological differences
between mouse and human systems as discussed previously [34].
However, some of this effect may also be due to differences in
sensitivity and specificity between the techniques used in these
studies. In fact, genes that have been experimentally shown to be
direct downstream targets of Oct3/4, such as Zfp42/Rex1 [24],
were not detected in either Boyer et al. or Loh et al. (see Figure 3A
for a complete list). Thus, we have decided to include all genes that
have been shown by either Boyer et al or Loh et al to be primary
targets of Oct3/4 in our list of Oct3/4 target candidates. We
compared our combined list (list 1 and list2) with the gene list by
Boyer et al. and that of Loh et al. We found that 372 genes were
overlapping with ChIP-based assay results and considered them
primary Oct3/4-target genes (Figure 3B). Figure 4A shows gene
symbols of 377 primary target genes (372 genes plus five well-
known Oct3/4-target genes that were not included in the ChIP-
based assays; see Supplemental Table S8 for the details about
these genes). The remaining 4040 genes, which were included in
either list 1 or list 2 of our Oct3/4-downstream candidate genes,
but not included in Oct3/4-binding target by either ChIP-on-chip
or ChIP-PET studies, should be considered as the secondary or
tertiary targets of Oct3/4. These genes are most likely regulated by
the primary target genes of Oct3/4.
Unlike the informatic searching of Oct3/4-binding motifs or
ChIP-based assays, expression profiling data can also provide the
information about the direction of regulation, i.e., whether the
downstream genes are up-regulated or down-regulated by the
repression of Oct3/4 in ZHBTc4 ES cells. Out of 396 primary
target genes, 159 genes belong to the former category, whereas
213 genes belong to the latter category (Figure 3B, 4A). Out of
4040 secondary/tertiary target genes, 2238 genes belong to the
former category, whereas 1802 genes belong to the latter category
(Figure 3B). Therefore, the expression profiling of Oct3/4-
manipulated ES cells provides important insights into not only
the structure, but also the dynamics of Oct3/4-regulated gene
networks. The results clearly demonstrate that both ChIP-based
assays and expression profiling of Oct3/4-manipulated ES cells
are required to delineate the downstream cascades of Oct3/4-
regulated genes.
To gain insights into the functions of the 372 primary Oct3/4-
downstream candidate genes, we analyzed GO annotations of
these genes. Out of these genes, 287 genes had GO annotations
Figure 3. Delineation of Oct3/4-downstream target gene network. (A) A list of genes that have been experimentally demonstrated as the direct
downstream targets of Oct3/4. Yes: genes that were also detected by the global ChIP assays. No: genes that were not detected by the global ChIP
assays. Mouse homologues of human genes identified in Boyer et al. were generated using NCBI HomoloGene Build 49. (B) Comparison of gene lists
obtained by the expression profiling (list 1 plus list 2) and global ChIP assays.
doi:10.1371/journal.pone.0000026.g003
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PLoS ONE | www.plosone.org 5 December 2006 | Issue 1 | e26Figure 4. (A) Primary targets of Oct3/4. Genes are separated into four groups: Genes detected by the current expression profiling, mouse ChIP-PET
assay, and human ChIP-on-chip assay; previously known target genes that were also detected by the current expression profiling; Genes detected by
the current expression profiling and mouse ChIP-PET assay; Genes detected by the current expression profiling and human ChIP-on-chip assay. Genes
classified as transcription factors by GO annotation were shown in bold. Genes that were down-regulated by the repression of Oct3/4 in ZHBTc4 cells
were shown in blue. Genes that were up-regulated by the repression of Oct3/4 in ZHBTc4 cells were shown in red. (B) Representative GO categories
that are enriched in the primary targets of Oct3/4 in a statistically significant manner (FDR.0.05).
doi:10.1371/journal.pone.0000026.g004
Pou5f1-Regulated Genes
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threshold of FDR.0.05 (Supplemental Table S9). Figure 4B
shows representative GO categories. Interestingly, one-fourth of
the 287 genes were involved in ‘‘transcription.’’ This indicates that
Oct3/4 can regulate a large number of genes by regulating many
transcription factors, which in turn regulate their downstream
genes. Other notable GO categories include ‘‘cell proliferation,’’
which indicates the direct involvement of Oct3/4 in the regulation
of cell proliferation. A significant fraction of genes annotated as
‘‘enzyme-linked receptor protein signaling pathway’’ and ‘‘Wnt
receptor signaling pathway’’ indicate that Oct3/4 directly
regulates key cellular signaling pathways in ES cells. Oct3/4 also
directly regulates genes involved in various ‘‘system development’’
sub-categories, such as ‘‘nervous system development,’’ ‘‘angio-
genesis,’’ and ‘‘lung development.’’ The direct regulation of the
variety of cellular and developmental processes by Oct3/4 is
consistent with the profound and diverse effects of Oct3/4
expression levels in ES cells.
Validation of candidate genes for downstream
targets of Oct3/4
Global gene expression analyses of Oct3/4-manipulated ES cells
have provided an independent validation to the primary target
genes identified de novo by the ChIP-on-chip [33] or ChIP- PET
[34] analysis, so it stands to reason that the list of genes identified
by combining all three data sets, shown in Figure 3B and 4A, is the
most reliable at this point. However, to meet more rigorous
molecular biology standards, whether these genes are indeed
directly regulated by Oct3/4 have to be validated individually by
standard molecular biological techniques such as electrophoretic
mobility shift assays (EMSA) and luciferase reporter assays. Such
validations, however, are not straightforward. It is well-known that
genes can be regulated by cis-regulatory elements that are located
far from the transcription start sites. Isolating and assaying a few
kb upstream region of these target genes would not suffice to
conclude whether the genes can be directly regulated by Oct3/4
or not. Especially, it will be difficult to establish that genes cannot
be regulated by Oct3/4, because the cis-regulatory elements may
not be included in the genomic region assayed in vitro. Neverthe-
less, we tested this strategy to validate at least a gene from this
target gene list.
First, we selected four putative primary target genes in a rather
arbitrarily manner: Trh, Tcl1, and Id2 were selected from top 30
gene lists in Figure 2D and Nfatc2ip was selected from a gene list in
Figure 4A. We also selected Zfp42 as a positive control. We
amplified by PCR the ,2 kb upstream putative promoter regions
of these genes (Supplemental Figure S2). To investigate whether
Oct3/4 can indeed regulate the expression of these genes, we
constructed a luciferase reporter gene driven by the upstream
putative promoter region and cotransfected it with or without an
Oct3/4-expressing plasmid into 3T3 mouse fibroblast cells. Of 5
reporter constructs, the two constructs containing Tcl1 and Zfp42
promoters were activated by Oct3/4, as judged by more than 2-
fold difference in luciferase activity (Figure 5A). To confirm
regulation in a more natural context, we transfected each reporter
construct into ZHBTc4 cells, where Oct3/4 levels can be
repressed by Tet. Constructs with Trh, Tcl1, and Zfp42 promoters
responded to Oct3/4, as judged by more than 2-fold difference of
luciferase activity in the presence or absence of Tet (Figure 5A).
Notably, Tcl1 showed even a stronger response than Zfp42,a
well-known downstream target of Oct3/4 (Figure 5A). These
results identified at least Tcl1, along with Zfp42, as regulated by
Oct3/4.
In order to identify Oct3/4 regulatory elements, a series of 59-
deletion mutants of the Tcl1 promoter were generated and
transfected into the ZHBTc4 cells. The luciferase reporter assay
revealed that deletion of two regions that cover 20.8 kb ,
21.3 kb and 20.4 kb , 20.5 kb, where variant Octamer-binding
motifs were found, sharply reduced the responsiveness to Oct3/4
(Figure 5B). We further examined whether Oct3/4 binds to these
motifs by electrophoretic mobility shift assays (EMSA) (Figure 5C).
As a control, a c1-oligonucleotide that contains the established
Oct3/4-binding motif of Zfp42 was used. For the Oct3/4-binding
motifs of Tcl1, we used an s1 oligonucleotide that contains an
AAAGGCAT motif and an s2 oligonucleotide that contains an
ATGTAGAT motif (Figure 5E). The s2 oligonucleotide, but not
the s1 oligonucleotide, showed a distinctive band after incubation
with ES cell lysates. The band was shifted by Oct3/4 antibody and
disappeared when a 2-bp mutation was introduced into the Oct3/
4-binding motifs (Figure 5C). Thus, Oct3/4 present in ES cell
lysates binds to the s2 oligonucleotide. To further narrow the
region, a series of single-base mutant oligonucleotides were
generated and subjected to EMSA. The results clearly showed
that ‘‘ATGTAGAT,’’ located 410 bp upstream of the Tcl1 gene, is
a functional Oct3/4 binding site (Supplemental Figure S3B, C).
To further confirm the binding of Oct3/4 in vivo, we performed
chromatin immunoprecipitation (ChIP) analysis and demonstrated
that Oct3/4 indeed binds to the s2 region, but not to the s1 region
(Figure 5D). A luciferase assay using another series of finer deletion
mutants of the Tcl1 promoter further confirmed that the region s2
was indeed an Oct3/4-responsive element in ZHBTc4 cells
(Supplemental Figure S3A). Taken together, we conclude that
Oct3/4 binds to this variant Oct3/4-binding site (ATGTAGAT)
in the Tcl1 promoter region and directly activates its expression.
Interestingly, unlike other Oct3/4-binding sites, there is no Sox2-
binding site around this Oct3/4-binding site.
Functional analysis of Tcl1 in ES cells
To gain insights into the functional involvement of Tcl1 in the
Oct3/4 pathway in ES cells, Tcl1 expression was knocked down by
transfecting siRNA against Tcl1 (siTcl1). The proliferation of ES
cells was significantly reduced in a dose-dependent manner
(Supplemental Figure S4A). Unlike the suppression of proliferation
when Oct3/4 expression is repressed in ZHTc4 cells, this
suppression of proliferation was not accompanied by any detect-
able morphological differentiation of ES cells (Supplemental
Figure S4A). However, it is conceivable that this rather general
proliferation suppression phenotype might be caused by either
non-specific or off-target effects of siRNA. To address this issue,
we first generated mouse ES cell clones (Tcl1-ROSA) with a Tet-
controllable Tcl1 gene by integrating the ORF of Tcl1 into
a ROSA locus [41]. We then established multiple ES cell clones,
where a plasmid expressing shRNA against the 39-UTR of Tcl1
(shTcl1) was stably transfected into the Tcl1-ROSA ES cell clone.
In these mouse ES clones (named shTcl1#2-1, shTcl1#2-5,
shTcl1#2-7, and shTcl1#3-3), the expression of endogenous Tcl1
was constitutively repressed by shRNA, but the expression of
exogenous Tcl1 was repressed only when Tet was added to the cell
culture medium. Consistent with the transient siRNA results, the
repression of Tcl1 suppressed the proliferation of ES cells
(Figure 6A). The reductions of Tcl1 in these ES cells at RNA
level and protein level were confirmed by the RT-PCR and
Western blot (Figure 6B). Because the proliferation of a parental
cell line (EBRTcH3) was not suppressed by Tet (Figure 6C), the
suppression of proliferation observed here was indeed caused by
the repression of Tcl1. The suppression of proliferation by the
repression of Tcl1 was also reversible even after 4 days of culture
Pou5f1-Regulated Genes
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contrast to the irreversible effects of Oct3/4-repressed conditions,
which not only reduce cellular proliferation, but also differentiate
ES cells into the trophoblast lineage.
Further support for the notion that Tcl1 acts on cell
proliferation but is not directly involved in the differentiation of
ES cells came from the microarray analysis of siTcl1-transfected
ES cells. Hierarchical cluster analysis of the selected 1,043 genes
that represent PC2(2) in ZHBTc4 cells (Figure 2B) indicated that
ZHBTc4 cells showed changes from an expression pattern like ES
cells (d0) to a pattern like TS cells (d2) (Supplement Figure S5A,
Supplemental Table S10). Unlike ZHBTc4 cells at a comparable
time point (d2), siTcl1-transfected ES cells showed an expression
pattern like ES cells (Supplemental Figure S5A). In particular,
genes involved in cell proliferation regulation showed similar
expression changes in siTcl-transfected ES cells and ZHBTc4 cells
(Supplemental Figure S5B), whereas trophoblast-lineage markers
were not significantly upregulated in siTcl1-transfected ES cells.
The microarray analyses were thus consistent with the phenotypic
changes observed in ES cells following repression of Tcl1:
slowdown of proliferation, but no differentiation towards the
trophoblast lineage. Consequently, Tcl1 seems to fractionate the
effects of repression of Oct3/4, which causes both the slowdown of
proliferation and the differentiation into trophoblast cells.
To investigate whether Tcl1 is a major mediator of the effects of
Oct3/4 on the proliferation of ES cells, we established multiple
stable cell clones (Tcl1-#2A1, Tcl1-#2D5, and Tcl1-#1A6) by
transfecting a plasmid vector constitutively expressing Tcl1 into
ZHBTc4 ES cells. In these cells, the repression of Oct3/4 by Tet
does not cause the repression of Tcl1, and therefore, the effect of
Oct3/4 repression can be uncoupled with the repression of Tcl1.
However, the results clearly showed that the constitutive
expression of Tcl1 could not prevent the suppression of ES cell
proliferation (Figure 6E).
The only known function of Tcl1 protein is to enhance the
kinase activity of Akt1 (thymoma viral proto-oncogene 1) in
leukemia cells [42]. Akt1 is a key kinase in the Ras/PI3K/Akt1
signaling pathway [43]. To investigate whether Tcl1 also activates
Akt1 in ES cells, Western blot analysis was performed. The total
amount of Akt1 protein was unchanged, but the active form of
Figure 5. Tcl1 is regulated by Oct3/4. (A) Luciferase assay for 4 candidate Oct3/4 target genes and one known target gene (Zfp42). (B) Luciferase
assay for deletion analysis of region upstream of Tcl1 gene. s1 and s2 are candidates for Oct3/4 binding sites, with sequence shown in (E). (C) EMSA
for two candidate sites. The arrow indicates the band for Oct3/4/oligonucleotide binding. (D) ChIP assay of two target sites (see Experimental
Procedures). (E) The sequence around s1 and s2 sites and the position of mutations for EMSA oligos (blue nucleotides).
doi:10.1371/journal.pone.0000026.g005
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Tcl1-repressed ES cells (Figure 6B). Similar results were obtained
in siTcl-transfected ES cells (Supplemental Figure S4B). The
suppression of ES cell proliferation by the repression of Tcl1 was
restored by the transfection of a plasmid expressing a constitutively
active form of Akt1 (caAkt1), suggesting that Akt1 mediates at least
some of the proliferation-reducing action of Tcl1 in ES cells.
Finally, it is worth mentioning that Oct3/4 expression levels were
not changed when Tcl1 expression was repressed (Figure 6B),
suggesting that there is no feedback loop from Tcl1 to Oct3/4.
DISCUSSION
Oct3/4 plays a central role in the maintenance of undifferentiated
ES cells, which are characterized by their pluripotency and self-
renewal activity. It has also been shown that Oct3/4 plays critical
Figure 6. Functional analysis of Tcl1 in ES cells. (A) Expression level of Tcl1 gene effects on cell proliferation. The number of ES cells decreased when
Tcl1 was knocked down by shRNA. (B) RT-PCR and Western blot analysis of ES cells with shRNA of Tcl1 gene. Tcl1 gene expression affected active Akt1
(p-Ser.473 Akt1), but not wild type of Akt1. (C) Reversibility of Tcl1 downregulation effect. The number of cells was rescued in the absence of Tet. (D)
Photomicrographs of ES cell cultures. The number of ES cells decreased when Tcl1 was knocked down by shRNA. Cell proliferation was rescued in the
absence of Tet. (E) Overexpression of Tcl1 does not rescue cell proliferation while Oct3/4 is repressed. (F) A model for the involvement of Oct3/4-Tcl1-
Akt in ES cell proliferation.
doi:10.1371/journal.pone.0000026.g006
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development. As a first step to understand the diverse roles of
Oct3/4, we have carried out global expression profiling of mouse
ES cells, where the expression level of Oct3/4 is manipulated
using a Tet-inducible system.
Differentiation of ES cells by the manipulation of
Oct3/4
It has been shown previously, by the detection of a few marker
genes using Q-PCR, that repression of Oct3/4 leads to the
differentiation of ES cells into the trophoblast lineage, and that
overexpression of Oct3/4 leads to primitive endoderm and
mesoderm differentiation [19,44]. Our microarray analysis con-
firms that repression of Oct3/4 differentiates ES cells into the
trophoblast lineage by showing the global similarity of gene
expression patterns to those of TS cells. However, the analysis
indicates that ZHTc6 cells differentiate into more different cell
types than appreciated previously, suggesting that overexpression
of Oct3/4 alone does not completely determine the fate of ES
cells, but may rather facilitate differentiation by perturbing the
maintenance of self-renewal. This notion is consistent with recent
findings that the effect of Oct3/4 overexpression depends on
context. For example, overexpression of Oct3/4 enhances
differentiation towards neurons on PA6 stromal cells [45], whereas
it enhances differentiation towards beating cardiac muscles in
embryoid bodies and hematopoietic cells on OP9 stromal cells
(H.N., data not shown). Furthermore, overexpression of Oct3/4 in
vivo leads to a large array of developmental defects resulting in
embryonic lethality [46]. Genes identified here for their correla-
tion to differentiation (PC3(+) in Supplemental Figure S1C and
PC2(2) in Figure 2B) should provide good candidate genes for
early markers of various lineages.
A unique mode of gene expression regulation by
Oct3/4
One of the key features of Oct3/4-mediated gene expression
regulation in ES cells is that the Oct3/4 level has to be maintained
at an appropriate level. Either reduction or overexpression of
Oct3/4 triggers the differentiation of ES cells [19]. The current
work has revealed that many (at least 418) genes, 30 of which are
primary targets, are regulated in a peculiar manner: the same gene
is activated or repressed depending on the amount of Oct3/4
(Figure 1E). The presence of these ‘‘bell-shaped’’ and ‘‘inverse bell-
shaped’’ gene expression regulation relationships indicates that the
maintenance of appropriate Oct3/4 levels is built into the gene
regulatory network in mouse ES cells.
Two examples of such regulations by Oct3/4 have been
reported. First, Scholer et al. have shown that a promoter with
tandem repeats of octamer motif, which is transcriptionally active
in the presence of ordinary Oct3/4 levels, is repressed by excess
Oct3/4 [36]. The authors have proposed a ‘‘squelching’’ mech-
anism, i.e., a factor bridging between Oct3/4 and the basal
transcriptional initiation complex is absorbed by excessive
amounts of Oct3/4, making it unavailable for transcription [36].
Second, Ben-Shushan et al. has shown that the promoter of Zfp42/
Rex1 is activated by ordinary amounts of Oct3/4, but is repressed
by the overexpression of Oct3/4 [24]. The authors have pointed
out that this peculiar regulatory pattern has also been observed in
the case of Kru ¨ppel [47] and ATF-1 [48]. Although it is also possible
that bell-shaped or inverse bell-shaped expression systems are
caused by feedback regulatory loops, which may involve genes
acting further downstream, 49 primary Oct3/4 target genes that
fall into this category are most likely regulated in a similar manner
as Zfp42/Rex1.
Because these 49 primary target genes seem to be tightly linked
to the requirement of appropriate Oct3/4 levels for the
maintenance of the pluripotent/self-renewing state of ES cells,
these genes may play a critical role in the ES cells. Indeed, Nanog
and Sox2, which are often referred as critical genes for the
maintenance of pluripotency and self-renewal in ES cells, are
included in the bell-shaped gene expression category (Figure 1E).
Similarly, Esrrb, Fbxo15, Otx2, and Spp1/Opn are also frequently
referenced as critical to ES cell functions. Interestingly, Jarid2
(Jumonji, AT rich interactive domain 2) and Jmjd1a - two proteins
with Jumonji domains–are included in this list. It has been shown
recently that proteins with Jumonji domains are involved in
chromatin modification [49], especially demethylation of histones
[50]. The involvement of Id2, which is grouped in the inverse bell-
shaped gene expression category (Figure 1E), in the maintenance
of a pluripotent/self-renewing state in mouse ES cells [6] also
seems to have important implications. Genes in this list will
therefore be important targets for future studies.
Genes downstream of Oct3/4
The current work clearly demonstrates that both global ChIP
assays and global expression profiling are required to understand
the gene regulatory network governed by a transcription factor.
Global ChIP assay provides the structure, i.e., connections or
wiring of the gene regulatory network, whereas the global
expression profiling provides the dynamics, i.e., behavior or
kinetics of the gene regulatory network. For example, ChIP-on-
chip assays of human ES cells [33] and ChIP-PET assays of mouse
ES cells [34] have provided a large list of primary target genes
whose regulatory sequences, e.g., enhancers/promoters, can be
bound by Oct3/4. However, these global ChIP assays cannot
provide information about whether Oct3/4 activates or represses
the expression of these downstream genes. Such information can
be obtained only by doing the global gene expression profiling of
ES cells in which the Oct3/4 level is specifically altered. In this
report, the global expression profiling of Oct3/4-repressed mouse
ES cells uncovered ,4500 candidate genes as potential down-
stream targets of Oct3/4. Although it is not easy to distinguish the
primary or secondary target genes by global expression profiling
alone, the meta-analysis of the combined data sets of global ChIP
assays and global expression profiling were able to dissect the
downstream gene regulatory network of Oct3/4 as summarized in
Figure 3 and 4 (see a complete list in Supplemental Table S8). In
this diagram, primary targets and the secondary/tertiary targets of
Oct3/4 are separated and the directions (up or down) of
regulations are also shown.
While the earlier version of this manuscript was being peer-
reviewed and revised for another journal, microarray analyses of
mouse ES cells after the repression of Oct3/4 by transient siRNA
[34] and stable shRNA [51] were reported. Ivanova et al. reported
that the expressions of 1133 genes (1072 with gene symbols) are
altered [51], whereas Loh et al. reported that the expressions of
4620 genes are altered [34]. Considering recent reports on the
broad off-target effects of siRNA/shRNA [52–54], it is conceiv-
able that these microarray data might include genes, the
expressions of which are altered by the repression of genes other
than Oct3/4. In contrast, the current microarray data have been
obtained from ES cells, where only the Oct3/4 level is
manipulated by Tet, and therefore, genes identified as primary
or secondary downstream of Oct3/4 in this work are most likely
affected directly or indirectly by Oct3/4.
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Among these downstream candidate genes, we were able to
establish that Tcl1 is a new direct target gene of Oct3/4, based on
several lines of evidence: promoter activity assays by luciferase
reporter in Oct3/4-cotransfected fibroblast cells and ES cells; direct
binding by in vitro EMSA assay; and in vivo binding assay by ChIP.
We also established the sequence 59-ATGTACAT-39 as a new
variant form of the Oct3/4 binding site.
Tcl1 has been extensively studied as an oncogene in T cell
leukemia [55], but our findings suggest that Tcl1 also plays an
important role in early mouse embryos and ES cells. This notion is
indeed consistent with earlier reports on the expression patterns of
Tcl1: it is highly expressed in unfertilized eggs and gradually
downregulated during preimplantation development [37]; it is one
of the 88 genes whose average expression levels correlated with the
gradual loss of developmental potency during development [56];
and it is also one of the ES-enriched genes informatically found
together with Nanog [16]. A gene disruption study also showed
that a majority of embryos depleted in maternal Tcl1 are unable to
reach the blastocyst stage, although Tcl1
2/2 embryos surviving to
birth appear normal except for reduced numbers of lymphocytes
in bone marrow, thymus, and spleen [57,58]. Very recently the
involvement of Tcl1 in the regulation of mouse ES cells has also
been shown [51].
In this paper, we have shown that the proliferation rate of ES
cells is controlled by Tcl1 in a dose-dependent manner: over-
expression of Tcl1 increases the ES cell proliferation rate, whereas
the repression of Tcl1 reduces it. We have also shown that the
forced repression of Tcl1 primarily affects ES cell proliferation, but
not differentiation, based on morphology and microarray-based
gene expression patterns (Supplemental Table S10). As one of the
genes with a bell-shaped expression pattern relative to Oct3/4
level, both overexpression and repression of Oct3/4 reduces the
expression level of Tcl1. These data suggest that the reduction of
ES cell proliferation caused by both overexpression and repression
of Oct3/4 is mediated by Tcl1–a primary target gene of Oct3/4
(Figure 6F). However, it is also clear that Tcl1 is not the only
primary Oct3/4 target gene that controls proliferation in ES cells,
because the constitutive expression of Tcl1 cannot prevent the
reduction of proliferation by the repression of Oct3/4 (Figure 6E).
Furthermore, it is important to point out that Oct3/4 is not the
only upstream gene for Tcl1, because we have observed that Tcl1
also responds immediately to the activation of Stat3 (Supplemental
Figure S6).
It has been shown that Tcl1 enhances the kinase activity of Akt1
[42]. This was originally demonstrated in T-cells [42,59–61], but
we find that the level of p-Ser.473-Akt1 is proportional to the level
of Tcl1, and thus, the same mechanism also seems to function in
ES cells. The rescue of the siTcl1-induced phenotype by
a constitutively active form of Akt1 implies that Tcl1 acts through
Akt1 in ES cells. Akt1 is one of the key kinases whose activation
enhances cell proliferation and inhibits apoptosis. Akt1 associates
with PI(3,4,5)P3 at the cell membrane and is activated by
phosphorylation [62]. Tensin homologue PTEN suppresses this
PI phosphatidylinositol-3-OH-kinase (PI3K) pathway [63]. Simi-
larly, the recently identified Eras gene regulates ES cell pro-
liferation through PI3K [64]. Akt1 in turn phosphorylates
a number of proteins, including the pro-apoptotic proteins BAD
and pro-caspase-9, GSK3, p21WAF1, MDM2, and the forkhead
family of transcription factors. Although Akt1 is known to be
involved in the control of either cell proliferation or apoptosis, we
observed no apoptosis by Annexin-V assays in siTcl1-transfected
ES cells (data not shown). Consistent with our findings, apoptosis
was also not evident in cleavage blocked Tcl1
2/2 embryos [57]. It
has also been shown recently that the activation of Akt is sufficient
to maintain the undifferentiated state of mouse ES cells [65].
Conclusions
Understanding the global gene network that governs the pluripo-
tency and self-renewal of ES cells is an important first step towards
the experimental manipulation of cellular developmental potency.
This is also important to understand the global architecture of
gene regulatory networks. We have shown in this paper the
analysis of dynamic changes in global gene expression patterns of
ES cells, in which a specific transcription factor is manipulated so
that it can be directly overexpressed or repressed. The approaches
used in this work can be applied to almost any transcription factor
as well as other key genes functioning in ES cells.
MATERIALS AND METHODS
Growth and differentiation of ES cells
ZHBTc4, ZHTc6, and EB5 ES cells were cultured without feeder
cells in LIF-supplemented medium as described [19,66]. For
differentiation, ZHTc6 cells were cultured in the absence of Tet,
which induced the overexpression of Oct3/4. ZHBTc4 cells were
cultured in the presence of Tet, repressing Oct3/4 expression.
Three independent samples were prepared for each time point.
Microarrays
Microarray experiments were carried out as described [35,37]
using the NIA Mouse 22K Microarray v1.0 (Development 60-mer
Oligo: Manufactured by the Agilent Technologies, #011321) [35].
Briefly, 5 mg total RNA was transcribed into double-stranded T7
RNA polymerase promoter-tagged cDNA, then amplified into
single-stranded, Cy3- or Cy5-tagged cRNA by T7 polymerase.
Each sample for Oct3/4 overexpression was hybridized against
the day 0 ZHTc6 sample for 16 hours at 60uC on the microarrays.
Oct3/4 repression samples were hybridized against the day
0 ZHBTc4 sample. After washing, microarrays were scanned
with an Agilent DNA Microarray Scanner. Dye-swapped
hybridization pairs were done for each sample. For comparisons
among TS and ES (R1) cells, siTcl1-transfected ES cells, ZHTc6
and ZHBTc4 cells, each sample was hybridized against a common
reference pool of RNA. Total RNAs from TS cells [38] and R1 ES
cells [67] were kind gifts from Dr. Janet Rossant. All microarray
data are available at http://lgsun.grc.nia.nih.gov/ANOVA/ and
are also available at the public microarray database (GEO
[Accession number: GSE5936] and ArrayExpress [Accession
number: E-MNIA-61]).
Data handling
Feature Extraction software (Agilent Technologies, Palo Alto,
California) was used to process scan images and extract
quantitative numerical spot data. Of 21,939 spots, 20,251 spots
were identified as within 0.03 error valance in the three
replications. Cluster analyses were performed using TIGR MEV
software (http://www.tigr.org). The x
2
ij -value of correlation
between each cluster (Figure 1D) was calculated by Chi-square
statistic (x
2
ij=(N*fij2Sij)2/(N*Sij), here Sij=Sfi* Sfj). Spots were
required to have a signal over background of at least 2.5 log
(intensity) on average to be included in further analyses. For the
ZHTc6 time course, 16,216 spots met this criterion, as did 15,182
spots for the ZHBTc4 time course. A total of 14,690 spots passed
in both of the cell lines. Of those data, statistically significant
differentially expressed genes were identified using the False
Discovery Rate (FDR) method [68] in the NIA Array Analysis
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sponds to the average proportion of false positives=5% or 1%.
PCA analysis was performed using FDR=5% for both cell lines.
For comparisons of ZHBTc4 and ZHTc6 cells, TS and ES cells,
and siTcl1-transfected ES cells, each data set was combined
through a universal control sample.
Construction of expression vectors, reporter
plasmids, and luciferase reporter assay
The Oct3/4 expression vector, pcDNA-Oct3/4, was constructed
by inserting a PCR product from ES cell cDNA into the EcoRI
site located downstream of the CMV promoter in pcDNA3.1(+)
(Invitrogen, Carlsbad, California). Luciferase reporter plasmids
were constructed by inserting upstream regions of each gene (see
Supplemental Figure S3) into pGL3-Basic vector (Promega,
Madison, Wisconsin). All inserts were amplified by genomic
PCR and confirmed by sequencing of both of strands. Each PCR
primer is described in Supplemental Figure S3. For the luciferase
reporter assay in fibroblast 3T3 cells, 40 ng of reporter plasmid
DNA was cotransfected into 2610
4 cells with 40 ng of pcDNA-
Oct3/4, 10 ng of pRL-TK (Promega, Madison, Wisconsin) and
310 ng of pGL3-Basic (Promega, Madison, Wisconsin) using
Lipofectamine plus (Invitrogen, Carlsbad, California). Two days
after transfection, luciferase activities were measured by the dual
luciferase assay system (Promega, Madison, Wisconsin). Triplicate
samples were analyzed. The relative activities were calculated
from the ratios of luciferase activities in the presence or absence of
pcDNA-Oct3/4. Luciferase assays in ES cells were performed
using ZHBTc4 cells. The level of Oct3/4 expression can be
manipulated in this cell line by a Tet-inducible system [19]. The
relative activities were calculated from ratios of luciferase activity
in the presence and absence of Tet after 24 hours.
EMSA and ChIP
Nuclear extracts from ES cells were isolated by using NE-PER
Nuclear Extraction Reagents (Pierce Biotechnology, Rockford,
Illinois) in the presence of protease inhibitors. DNA mobility shift
assays were performed as previously described [40], using nuclear
extracts from ES cells and biotinylated oligonucleotides, then
transferring to nylon membrane, followed by detection using
a Chemiluminescent Nucleic acid detection module kit (Pierce
Biotechnology, Rockford, Illinois). Oligo sequences for EMSA:
s1, 59-CGTGGTGGCACATGCCTTTAATCACAGCAC-39
and 59-GTGCTGTGATTAAAGGCATGTGCCACCACG-39;
s2, 59-CTGCGAGGTCCATCTACATATCTTCCTCCC-39
and 59-GGGAGGAAGATATGTAGATGGACCTCGCAG-39.
Oct3/4 monoclonal antibody was ‘C-10’ from Santa Cruz
Biotechnology (Santa Cruz, California). Chromatin immunopre-
cipitation was performed using ChIP-IT
TM from Active Motif
(Carlsbad, California), per the manufacture’s protocol, using anti-
mouse immunoglobulin G (IgG) as a control and monoclonal
antibody of Oct3/4 (C-10) from Santa Cruz Biotechnology (Santa
Cruz, California). Fragments of the target site were amplified by
PCR with the following primers: 59-GAATACTGAAGGC-
CAAGGTC and 59-AAAGAAAGCCAGGCGTGGTG for s1
site; and 59-AGAGAGAACCCGGGAGGAAGATA and 59-
CTTATGGTGAGACCCCTAG for s2 site. ExTaq polymerase
(Takara, Tokyo, Japan) was used with 30 and 35 cycles in standard
protocols.
siRNA of Tcl1 gene and Western blot analysis
siRNA were co-transfected into EB5 ES cells (2610
5 cells/ml) with
100 ng of pPyCAGIP-IRES-puromycin vector using Lipofecta-
mine 2000 (Invitrogen Carlsbad, California). The siRNA
sequences were designed as described previously [70]. siRNA
sequences for mouse Tcl1 and for the control (siGFP) are as
follows: 59-GTCATCAAGAGTAATGAAAAATT-39 and 59-
CAGCCACAACGTCTATATCATGG-39. One day after trans-
fection, cells were selected by the addition of Puromycin for
24 hours. For western blot analysis, cells were washed with ice cold
PBS, then lysed with RIPA buffer (50 mM Tris-Cl, pH7.5,
150 mM NaCl, 0.5% sodium deoxycholate, 1% NP40, 0.1% SDS
containing protease inhibitor cocktail (Sigma, St. Louis, Missouri)
and phosphatase inhibitor cocktail (Sigma, St. Louis, Missouri)).
Whole cell extracts were analyzed on 10% SDS-polyacrylamide
gels, followed by immunoblotting on nitrocellulose membranes
(Amersham, Piscataway, New Jersey), blocked with 5% non fat dry
milk in TBST (Trizma base, 140 mM NaCl, 0.05% Tween-20)
and probed with the indicated antibodies at 4uC. All antibodies
were purchased from Cell Signaling (Beverly, Massachusetts). For
the rescue experiment, EB5 ES cells were transfected with a 1:9
mixture of each siRNA and either pPyCAG-wtAkt1 (wild type) or
pPyCAG-caAkt1 (constitutively active Akt1). The cells were then
cultured as described above, and viable cell counts were
determined by trypsinizing and staining with trypan blue.
Isolation of Tcl1 manipulated ES cells
For the isolation of ES cells, which have the overexpression of Tcl1
gene using ROSA-Tet system (Tcl1-ROSA-Tet), we have done as
previous described methods [41]. Briefly, 5 mg of circular plasmid
DNA of Tcl1 exchange vector (pZhC-Tcl1), which have only cds
region of Tcl1 gene, and pCAGGS-Cre were co-transfected into
EBRTcH3 ES cells. ES cells were cultured in regular medium
within 18 mg/ml zeocin, and then, the 36 clones of ES cells were
isolated. Of 36 clones, 12 clones had overexpression of exogenous
Tcl1 gene without Tet in the culture medium. For the knocked
down of Tcl1 gene by shRNA, we designed the target oligo DNA
(59- CCGCGTCCTGTCGCTGATTAAATTTCAAGAGATT-
TAATCAGCGACAGGACGTTTTTTGGAAA -39) having 39
non-coding region of Tcl1 gene. It will be only downregulated for
endogenous Tcl1 expression. After cloning to pSilencer 2.1-U6
vector (Ambion), 5 mg of plasmid DNA were transfected to Tcl1-
ROSA-Tet ES cells (26105 cells/ml) by using Lipofectamine 2000
(Invitrogen). We isolated 24 clones of resistant of puromycin
(80 mg/ml), and analyzed the 4 clones, shTcl1-#2-1, #2-5, #2-7
and #3-3.
For overexpression of Tcl1 gene in ZHBTc4 ES cells, at first,
amplified PCR products of Tcl1 gene were cloning to pCAG-
IRES-puro vector. After confirming the sequences, 5 mg of pCAG-
IRES-puro-Tcl1 plasmid DNA were transfected to ZHBTc4 ES
cells (2610
5 cells/ml) by using Lipofectamine 2000 (Invitrogen).
ES cells were cultured in the medium within 80 mg/ml puromycin,
and then, the 24 clones of ES cells were isolated. Of 24 clones,
three clones were analyzed (Tcl1-#2A1, 2D5 and #1A6).
Western blot analysis and counting the cell numbers have done
by same as previous methods.
SUPPORTING INFORMATION
Figure S1 Principal component analysis (PCA) for ZHTc6 cells
(A) 2D-views of PCA for 2,757 genes that were identified as
significantly differentially expressed during the time course of 5
days. (B) The expression pattern and ES/TS specificity of each
component of PCA was classified into 4 groups (Group I,Group
IV). In the PC2(+) axis, the expression of genes contributing to this
component (326 genes in ZHTc6-Group I; 1510 genes in ZHTc6-
Group II) showed transient responses at days 1 and 2, and then
Pou5f1-Regulated Genes
PLoS ONE | www.plosone.org 12 December 2006 | Issue 1 | e26gradually returned to the original state. That the transient
response is a major PC is consistent with the results of k-means
clustering analysis (see Figure 1B). In contrast, PC3(+) represented
unidirectional changes, which seem to correspond to the
differentiation of ES cells. Although this is a relatively minor
component (116 genes in ZHTc6-Group III; 89 genes in ZHTc6-
Group IV), many of these genes were characterized.
Found at: doi:10.1371/journal.pone.0000026.s001 (0.90 MB TIF)
Figure S2. Map of the genome for Oct3/4 target candidate
genes. For each gene, primer sequences (FW/RV) were used to
amplify a target genomic region.
Found at: doi:10.1371/journal.pone.0000026.s002 (0.72 MB TIF)
Figure S3. Promoter analysis of upstream of Tcl1 gene(A)
Luciferase assay of deletion mutants in ZHBTc4 cells. White box
are deletion region. (B) Sequences for promoter analysis. Blue
color sequence was used for EMSA (C) EMSA of point mutation
(red color in the sequences) for Oct3/4 binding region.
Found at: doi:10.1371/journal.pone.0000026.s003 (1.47 MB TIF)
Figure S4. siRNA analysis of Tcl1 gene(A) Photomicrographs of
ES cell cultures. The number of ES cells decreased when Tcl1
siRNA was added, but luciferase siRNA (control) showed no effect.
(B) Western blot analysis of active Akt1s. The antibody to p-
Ser.473 Akt1 detected the active form of Akt1. (C) Wild type Akt1
(wtAkt1) could not rescue Tcl1 siRNA-treated cells, but they were
rescued by constitutively active Akt1 (caAkt1).
Found at: doi:10.1371/journal.pone.0000026.s004 (1.96 MB TIF)
Figure S5. Gene expression analysis of ZHBTc4, siTcl1, ES and
TS cells (A) Hierarchical clustering analysis of 1043 genes that
were identified as Group I and II in ZHBTc4 cells. (B) The
expression pattern of the genes that were related to cell cycle and
trophoblast lineage. siTcl1/siGFP data was shown at day 2 after
transfection (see Experimental Procedures).
Found at: doi:10.1371/journal.pone.0000026.s005 (1.49 MB TIF)
Figure S6. The effects of LIF on the gene expressions of Tcl1,
Trh, Nanog and Socs3. ZHBTc4 ES cells were cultured without
feeder cells in LIF-supplemented medium or withdraw LIF. EB5
ES cells were cultured for 24 hours without LIF, and then, added
to LIF at time zero. Total RNA was isolated from ES cells by
TRIZOL Reagent (Invitrogen). For RT-PCR analyses, cDNA was
synthesized from 1 mg of total RNA, with an oligo-dT primer and
Moloney murine leukemia virus RT (ReverTra Ace, Toyobo).
1/40 of the single strand cDNA products were used for each
PCR amplification with iQ SYBR Green Supermix and iCycler
iQ (Bio-Rad) and all data were normalized by expression
levels of GAPDH. Primer sets are listed below; Tcl1 S,
TTGCTCTTATCGGATGCCATGGCTAC; Tcl1 AS, GGTC-
TGGGTTATTCATCGTTGGACTC: Trh S, GCGACTCCAA-
GATGCAGGGACCTTG: Trh AS, CTCTAACCTTACTCC-
TCCAGAGGTTC: Nanog S, ACCTGAGCTATAAGCAGGT-
TAAGAC: Nanog AS, GTGCTGAGCCCTTCTGAATCA-
GAC: GAPDH S, ACCACAGTCCATGCCATCAC: GAPDH
AS, TCCACCACCCTGTTGCTGTA.
Found at: doi:10.1371/journal.pone.0000026.s006 (0.70 MB TIF)
Table S1. The expression pattern of the 20251 genes in the time
course of ZHTc6 and ZHBTc4 cells. Each value was normalized
as ’0’ in time zero.
Found at: doi:10.1371/journal.pone.0000026.s007 (5.75 MB
XLS)
Table S2. A complete list of genes that show "bell-shaped"
expression patterns.
Found at: doi:10.1371/journal.pone.0000026.s008 (0.11 MB
XLS)
Table S3. A complete list of genes that show "inverse bell-
shaped" expression patterns.
Found at: doi:10.1371/journal.pone.0000026.s009 (0.10 MB
XLS)
Table S4. The 2,757 genes that were used in PCA. The
expression values were normalized by median of all log intensities.
Found at: doi:10.1371/journal.pone.0000026.s010 (1.14 MB
XLS)
Table S5. The expression pattern of the 12198 genes in siRNA
of Tcl1 gene (siTcl1). Genes involved in cell proliferation
regulation showed similar expression changes in siTcl-transfected
ES cells and ZHBTc4 cells. For example, CyclinD1 and Cdk2
were downregulated in both systems, whereas Cdkn1a/P21Cip1
and Rbl2/P130 were upregulated. These expression patterns
indicate the suppression of cell proliferation [71]. In contrast,
trophoblast-lineage markers were not significantly upregulated in
siTcl1-transfected ES cells. For example, Plac1 showed a 2.8-fold
increase at day 2 of ZHBTc4 cells, but was not increased in siTcl1-
transfected ES cells. Similarly, Krt2-8 showed a 14.3-fold increase
at day 2 in ZHBTc4 cells, but very little (1.4-fold) increase in
siTcl1-transfected ES cells. The microarray analyses were thus
consistent with the phenotypic changes observed in ES cells
following repression of Tcl1: slowdown of proliferation, but no
differentiation into trophoblast lineage. The Tcl1 thus fractionates
the effects of repression of Oct3/4, which causes both the
slowdown of proliferation and the differentiation into trophoblast
cells.
Found at: doi:10.1371/journal.pone.0000026.s011 (2.54 MB
XLS)
Table S6 Primary targets of Oct3/4. These were selected based
on a search for multiple OCT binding sites within 8000 to +2000
bp. The first file requires at least 3 sites with conservation .50%
Found at: doi:10.1371/journal.pone.0000026.s012 (2.19 MB
XLS)
Table S7 At least 5 sites with conservation .50%, and
mismatch score ,0.05.
Found at: doi:10.1371/journal.pone.0000026.s013 (1.04 MB
XLS)
Table S8 A list of genes containing gene lists from the PCA
analysis (Matoba et al., this paper), 0 hr vs 24 hrs analysis (Matoba
et al, this paper), human ES ChIP-on-chip (Boyer et al., 2005),
mouse ES ChIP-PET (Loh et al, 2006).
Found at: doi:10.1371/journal.pone.0000026.s014 (7.13 MB
XLS)
Table S9 A list of 160 statistically significant GO categories.
Found at: doi:10.1371/journal.pone.0000026.s015 (0.15 MB
XLS)
Table S10 Comparison between siTcl1 and ZHTc6/ZHBTc4
cells. The 325 genes, which were up- or down-regulated in siTcl1,
were classified into the groups of PCA in ZHTc6 or ZHBTc4 cells.
Found at: doi:10.1371/journal.pone.0000026.s007 (1.45 MB
XLS)
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